Standard Treatment Compliance of Participants, Effectiveness and Prognosis in Acute Respiratory Distress Syndrome

The Acute Respiratory Distress Syndrome (ARDS) is one of common clinical critically diseases. In the United States, the incidence of ARDS reaches 31%, which is one of the main causes of death in patients. There is no unified treatment process for ARDS currently and the treatment measures are not yet standardized, so the standardization of ARDS treatment processes is needed to reduce mortality in patients. Following the evidence-based medicine principles and six-step treatment standards of ARDS, this study uses the method of multi-center randomized controlled clinical trials to evaluate the standardized treatment process of ARDS, which provides the basis for the standardized treatment of ARDS.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Respiratory Failure Acute Respiratory Distress Syndrome Lung Diseases Respiration Disorders Respiratory Distress Syndrome Respiratory Insufficiency Respiratory Tract Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Zhongda Hospital

Nanjing, Jiangsu, 210009, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

aged ≥ 18 years
admitted to the ICU
according to the diagnostic criteria of ARDS Berlin definition，admit patients with severe ARDS

Exclusion criteria

age <18 years old
be expected to die within 24 hours
end-stage malignancies
be participating in other studies, which may affect the results of this study
DNI (do not intubation) and DNR (do not recovery) patients
family members do not agree to sign an informed consent

Treatment and study plan

Primary outcomes

Number of medical staff who comply the protocol treatment

Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Southeast University, China

Other

Registry information

Acronym: APT

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2015
First posted: Jul 1, 2014
Registry last updated: Jun 24, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed